Alto Ingredients financials
$3.63−1.09%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $917.9M | $965.3M | $1.22B | $1.34B | $1.21B |
| Gross profit | $34.9M | $9.7M | $15.7M | -$27.6M | $67.8M |
| Gross margin | 3.8% | 1.0% | 1.3% | −2.1% | 5.6% |
| Operating income | $7.4M | -$52.5M | -$23.6M | -$59.1M | $35.5M |
| Net income | $12.1M | -$60.3M | -$29.3M | -$42.9M | $44.2M |
| Net margin | 1.3% | −6.2% | −2.4% | −3.2% | 3.7% |
| Diluted EPS | $0.16 | $-0.82 | $-0.40 | $-0.60 | $0.61 |
| EBITDA | $33.9M | $5.4M | $9.9M | -$30.4M | $62.7M |
| Operating cash flow | $13.2M | -$3.5M | $22.0M | $6.0M | $26.8M |
| Free cash flow | $8.6M | -$14.6M | -$7.5M | -$31.7M | $10.4M |
| Diluted shares | 75.7M | 73.5M | 73.3M | 71.9M | 72.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $23.4M | $35.5M | $30.0M | $36.5M | $50.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $79.6M | $92.9M | $82.1M | $68.4M | $50.4M |
| Total assets | $388.8M | $401.4M | $454.2M | $478.3M | $485.0M |
| Total liabilities | $143.5M | $176.4M | $174.7M | $170.2M | $139.7M |
| Shareholders' equity | $245.2M | $225.1M | $279.6M | $308.1M | $345.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology